TY - JOUR
KW - Female
KW - Humans
KW - Mandatory Reporting
KW - Mass Screening
KW - Perinatal Care
KW - Pregnancc
KW - y
KW - Pregnancy Complications/diagnosis/therapy
KW - Substance-Related Disorders/diagnosis/therapy
KW - Terminology as Topi
AU - M. C. Smid
AU - M. Terplan
A1 - 
AD - Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah; and the Friends Research Institute, Baltimore Maryland.
BT - Obstetrics and gynecology
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 2
CY - United States
DO - 10.1097/AOG.0000000000004657
IS - 2
JF - Obstetrics and gynecology
LA - eng
M1 - Journal Article
PB - by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc
PP - United States
PY - 2022
SN - 1873-233X; 0029-7844
SP - 317
EP - 337
EP - 
T1 - What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period
T2 - Obstetrics and gynecology
TI - What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 34991147
U3 - 10.1097/AOG.0000000000004657
VL - 139
VO - 1873-233X; 0029-7844
Y1 - 2022
Y2 - Feb 1
ER -